Global High-Potent Oral Solid Dosage Contract Manufacturing Industry is poised to reach a commendable US$ 8.6 Billion valuation by 2033
The global high-potent oral solid dosage contract manufacturing industry demand is projected to witness substantial growth, surging from US$ 4.1 billion in 2023 to an estimated US$ 8.6 billion by 2033. This robust expansion, averaging a 7.6% Compound Annual Growth Rate (CAGR) throughout the forecast period, reflects the increasing demand for specialized facilities capable of…